Catherine A. Borg
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational study.
Journal: The European respiratory journal
Published: March 18, 2025
Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma.
Journal: The Journal of allergy and clinical immunology
Published: December 16, 2024
Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma.
Journal: The Journal of allergy and clinical immunology
Published: April 16, 2024
Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies.
Journal: Microbiology spectrum
Published: March 24, 2022
Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing.
Journal: Thorax
Published: July 21, 2021
Reply to Lipworth et al.: Don't Forget about Facilitatory Effects of Corticosteroids on β2-Adrenoceptors in Acute Asthma.
Journal: American journal of respiratory and critical care medicine
Published: September 24, 2020
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
Journal: The Lancet. Respiratory medicine
Published: August 31, 2020
Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma.
Journal: American journal of respiratory and critical care medicine
Published: June 26, 2020
Last Updated: 09/26/2026